Pepticom
AI platform for accelerating novel peptide therapeutic discovery and development.
About
Pepticom utilizes a unique Artificial Intelligence (AI) platform to accelerate and optimize the discovery of novel peptide therapeutics. Their technology, based on research from the Hebrew University, aims to overcome limitations in traditional drug discovery by efficiently identifying and designing peptide candidates. Teams look it up for Healthcare, Drug Discovery, Clinical Development.
Frequently asked
What does Pepticom do?
Pepticom is a Healthcare company that offers Software. Teams look it up for Drug Discovery, Clinical Development, Peptide Drugs. It is based in Jerusalem, Israel and was founded in 2011. Public records show about 16 people and $8M raised. Compare it on funding, headcount, reviews and nearby alternatives rather than the marketing line alone.
How much funding has Pepticom raised?
Pepticom has raised a total of $8M in funding. The most recent round on record is Funding Round.
Where is Pepticom headquartered?
Pepticom is headquartered in Jerusalem, Israel.
When was Pepticom founded?
Pepticom was founded in 2011.
What industry does Pepticom operate in?
Pepticom operates in Healthcare, Drug Discovery, Clinical Development, Peptide Drugs, Life Sciences.
How many employees does Pepticom have?
Pepticom has approximately 16 people on record.
Strength of the site’s backlink profile, on Ahrefs’ 0-100 Domain Rating scale. Licensed third-party data, not our opinion.
How well an AI agent can read and use this site: structured data, clean markup, and whether key facts are reachable without running JavaScript. We scan the live site.
Google PageSpeed mobile performance for the company’s own site. Measured by Google, not by us.